Visitor information – Everything you need to know about visiting our sites.
Alfred Health research outcomes are published in a wide range of peer reviewed journals.
Search or browse research publications by year, research area, publication type or keyword.
Publication Details
Quality Indicators for Global Benchmarking of Localized Prostate Cancer Management
Sampurno F, Zheng J, Di Stefano L, Millar JL, Foster C, Fuedea F, Higano C, Hulan H, Mark S, Moore C, Richardson A, Sullivan F, Wenger NS, Wittmann D, Evans S
(2018), J Urol, 200(2), 319-326
Early-onset baldness and the risk of aggressive prostate cancer: findings from a case-control study
Papa NP, MacInnis RJ, English DR, Bolton D, Davis ID, Lawrentschuk N, Millar JL, Severi G, Hopper JL, Giles GG
(2018), Cancer Causes Control, 29(1), 93-102
Brachytherapy-based radiotherapy with androgen deprivation for management of high-risk prostate cancer - time to reverse the declining trend?
Ong WL, Yaxley JW, Millar JL
(2018), BJU Int, 122 Suppl 5, 43591
DOI: 10.1111/bju.14487
Optimal Treatment for High-Risk Prostate Cancer
Ong WL, Koh TL, Millar J
(2018), JAMA, 320(4), 404-405
Under-utilisation of high-dose-rate brachytherapy boost in men with intermediate-high risk prostate cancer treated with external beam radiotherapy
Ong WL, Evans SM, Millar JL
(2018), J Med Imaging Radiat Oncol, 62(2), 256-261
In Regard to Yang et al
Ong WL, Evans S, Millar J
(2018), Int J Radiat Oncol Biol Phys, 100(5), 1294-1295
Development of Indicators to Assess Quality of Care for Prostate Cancer
Nag N, Millar J, Davis ID, Costello S, Duthie JB, Mark S, Delprado W, Smith D, Pryor D, Galvin D, Sullivan F, Murphy °C, Roder D, Elsaleh H, Currow D, White C, Skala M, Moretti KL, Walker T, De Ieso P, Brooks A, Heathcote P, Frydenberg M, Thavaseelan J, Evans SM
(2018), Eur Urol Focus, 4(1), 57-63
Randomized Trial of Systemic Therapy After Involved-Field Radiotherapy in Patients With Early-Stage Follicular Lymphoma: TROG 99.03
MacManus M, Fisher R, Roos D, O'Brien P, Macann A, Davis S, Tsang R, Christie D, McClure B, Joseph D, Jayamohan J, Seymour JF
(2018), J Clin Oncol, 36(29), 2918-2925
Understanding the Relationship Between Interactive Optimisation and Visual Analytics in the Context of Prostate Brachytherapy
Liu J, Dwyer T, Marriott K, Millar J, Haworth A
(2018), IEEE Trans Vis Comput Graph, 24(1), 319-329
Radiobiological parameters in a tumour control probability model for prostate cancer LDR brachytherapy
Her EJ, Reynolds HM, Mears C, Williams S, Moorehouse C, Millar JL, Ebert MA, Haworth A
(2018), Phys Med Biol, 63(13), 135011
Application of the 'Spiking' method to the measurement of low dose radiation (≤ 1Gy) using alanine dosimeters
Geso M, Ackerly T, Lim SA, Best SP, Gagliardi F, Smith CL
(2018), Appl Radiat Isot, 133, 111-116
Dose response and stability of water equivalent PRESAGE® dosimeters for synchrotron radiation therapy dosimetry
Gagliardi FM, Franich RD, Geso M
(2018), Phys Med Biol, 63(23), 235027
Water equivalent PRESAGE® for synchrotron radiation therapy dosimetry
Gagliardi FM, Day L, Poole CM, Franich RD, Geso M
(2018), Med Phys, 45(3), 1255
DOI: 10.1002/mp.12745
Interpolation to define clinical tumor stage in prostate cancer using clinical description of digital rectal examination
Evans SM, Murphy DG, Davis ID, Sengupta S, Borzeshi EZ, Sampurno F, Millar JL
(2018), Asia Pac J Clin Oncol, 14(5), e412-19
DOI: 10.1111/ajco.12875
Active surveillance of men with low risk prostate cancer: evidence from the Prostate Cancer Outcomes Registry-Victoria
Evans MA, Millar JL, Earnest A, Frydenberg M, Davis ID, Murphy DG, Kearns PA, Evans SM
(2018), Med J Aust, 208(10), 439-443
DOI: 10.5694/mja17.00559
Patterns of care and outcomes for men diagnosed with prostate cancer in Victoria: an update
Wang LL, Begashaw K, Evans M, Earnest A, Evans SM, Millar JL, Murphy DG, Moon D
(2018), ANZ J Surg, 88(10), 1037-1042
DOI: 10.1111/ans.14722
Transition Points for the Routine Integration of Palliative Care in Patients With Advanced Cancer
Collins A, Sundararajan V, Burchell J, Millar J, McLachlan SA, Krishnasamy M, Le BH, Mileshkin L, Hudson P, Philip J
(2018), J Pain Symptom Manage, 56(2), 185-194
Missing Evidence: Exploring Unpublished Trials in Victoria, Australia
Allan C, Chapman A, Parker C, Boltong A, Millar J
(2018), J Global Onc, Supplement 2, 96
DOI: 10.1200/jgo.18.28700
High neutrophil-to-lymphocyte ratio predicts poor prognosis in patients with squamous cell carcinoma of the head and neck treated with definitive chemoradiotherapy
Chandrasekara S, Davis S, Thomson P, Haydon A
(2018), Asia Pac J Clin Oncol, 14(5), e442-7
DOI: 10.1111/ajco.12846
Preclinical radiotherapy at the Australian Synchrotron's Imaging and Medical Beamline: instrumentation, dosimetry and a small-animal feasibility study
Livingstone J, Adam JF, Crosbie JC, Hall CJ, Lye JE, McKinlay J, Pelliccia D, Pouzoulet F, Prezado Y, Stevenson AW, Hâusermann D
(2017), J Synchrotron Radiat, 24(Pt 4), 854-65